Introducing the hormonal Intrauterine Device in Madagascar, Nigeria, and Zambia: results from a pilot study

Reprod Health. 2022 Jan 6;19(1):4. doi: 10.1186/s12978-021-01300-x.

Abstract

Background: The hormonal Intrauterine Device (IUD) is a highly effective contraceptive option growing in popularity and availability in many countries. The hormonal IUD has been shown to have high rates of satisfaction and continuation among users in high-income countries. The study aims to understand the profiles of clients who choose the hormonal IUD in low- and middle-income countries (LMICs) and describe their continuation and satisfaction with the method after 12 months of use.

Methods: A prospective longitudinal study of hormonal IUD acceptors was conducted across three countries-Madagascar, Nigeria, and Zambia-where the hormonal IUD had been introduced in a pilot setting within the of a broad mix of available methods. Women were interviewed at baseline immediately following their voluntary hormonal IUD insertion, and again 3 and 12 months following provision of the method. A descriptive analysis of user characteristics and satisfaction with the method was conducted on an analytic sample of women who completed baseline, 3-month, and 12-month follow-up questionnaires. Kaplan-Meier time-to-event models were used to estimate the cumulative probability of method continuation rates up to 12 months post-insertion.

Results: Each country had a unique demographic profile of hormonal IUD users with different method-use histories. Across all three countries, women reported high rates of satisfaction with the hormonal IUD (67-100%) and high rates of continuation at the 12-month mark (82-90%).

Conclusions: Rates of satisfaction and continuation among hormonal IUD users in the study suggest that expanding method choice with the hormonal IUD would provide a highly effective, long-acting method desirable to many different population segments, including those with high unmet need.

Keywords: Acceptability; Continuation; Hormonal IUD; Hormonal IUS; LARC; LNG-IUS; Satisfaction.

MeSH terms

  • Contraceptive Agents, Female*
  • Female
  • Humans
  • Intrauterine Devices*
  • Intrauterine Devices, Copper*
  • Levonorgestrel
  • Longitudinal Studies
  • Madagascar
  • Nigeria
  • Pilot Projects
  • Prospective Studies
  • Zambia

Substances

  • Contraceptive Agents, Female
  • Levonorgestrel